Zdrowie i gospodarka · 29/12/2015
FDA Corrects Public Hearing Notification for Human Cells, Tissues, or Cellular/Tissue-Based Products
The FDA is correcting a public hearing notification that appeared in the Federal Register, clarifying who must register for the hearing to provide input on recently issued draft guidances related to the regulation of human cells, tissues, or cellular/tissue-based products.